Burning Rock Biotech [BNR] vs Thermo Fisher [TMO] Detailed Stock Comparison

Burning Rock Biotech Ltd.

NASDAQ
Loading...

Thermo Fisher Scientific Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Burning Rock Biotech Ltd. wins in 7 metrics, Thermo Fisher Scientific Inc. wins in 11 metrics, with 0 ties. Thermo Fisher Scientific Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Burning Rock Biotech Ltd. Thermo Fisher Scientific Inc. Better
P/E Ratio (TTM) -0.61 25.84 Thermo Fisher Scientific Inc.
Price-to-Book Ratio 2.76 3.31 Burning Rock Biotech Ltd.
Debt-to-Equity Ratio 8.06 82.91 Burning Rock Biotech Ltd.
PEG Ratio 0.01 2.29 Burning Rock Biotech Ltd.
EV/EBITDA -499.77 19.02 Thermo Fisher Scientific Inc.
Profit Margin (TTM) -10.26% 15.15% Thermo Fisher Scientific Inc.
Operating Margin (TTM) -9.53% 17.89% Thermo Fisher Scientific Inc.
EBITDA Margin (TTM) N/A 17.89% N/A
Return on Equity -9.92% 13.52% Thermo Fisher Scientific Inc.
Return on Assets (TTM) -4.02% 5.00% Thermo Fisher Scientific Inc.
Free Cash Flow (TTM) $-98.24M $6.29B Thermo Fisher Scientific Inc.
Dividend Yield N/A 0.38% N/A
1-Year Return 200.65% 22.27% Burning Rock Biotech Ltd.
Price-to-Sales Ratio (TTM) 0.41 3.86 Burning Rock Biotech Ltd.
Enterprise Value $253.48M $214.76B Thermo Fisher Scientific Inc.
EV/Revenue Ratio 3.20 4.75 Burning Rock Biotech Ltd.
Revenue per Share (TTM) $50 $120 Thermo Fisher Scientific Inc.
Earnings per Share (Diluted) $-0.75 $18.18 Thermo Fisher Scientific Inc.
Beta (Stock Volatility) 1.60 0.97 Thermo Fisher Scientific Inc.
Short % of Float 0.87% 1.22% Burning Rock Biotech Ltd.

Burning Rock Biotech Ltd. vs Thermo Fisher Scientific Inc. Stock Performance Analysis

Loading Price Chart...

BNR
TMO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Burning Rock Biotech Ltd.-9.85%-28.59%-49.45%-63.08%-61.80%-55.84%
Thermo Fisher Scientific Inc.-1.69%3.89%2.45%-6.72%-18.35%-20.01%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Burning Rock Biotech Ltd.200.65%285.12%-65.34%-62.16%-62.16%-62.16%
Thermo Fisher Scientific Inc.22.27%-5.31%9.75%222.18%684.25%1,233.99%

Performance & Financial Health Analysis: Burning Rock Biotech Ltd. vs Thermo Fisher Scientific Inc.

MetricBNRTMO
Market Information
Market Cap i$221.68M$174.55B
Market Cap CategoryMicro capLarge cap
10 Day Avg. Volume i24,7222,356,220
90 Day Avg. Volume i31,6742,071,517
Last Close$8.69$473.95
52 Week Range$2.80 - $41.72$385.46 - $643.99
% from 52W High-79.17%-26.40%
All-Time High$41.69 (Jan 22, 2026)$672.34 (Dec 27, 2021)
% from All-Time High-79.16%-29.51%
Growth Metrics
Quarterly Revenue Growth0.00%0.06%
Quarterly Earnings GrowthN/A0.10%
Financial Health
Profit Margin (TTM) i-0.10%0.15%
Operating Margin (TTM) i-0.10%0.18%
Return on Equity (TTM) i-0.10%0.14%
Debt to Equity (MRQ) i8.0682.91
Cash & Liquidity
Book Value per Share (MRQ)$7.49$141.96
Cash per Share (MRQ)$4.57$8.75
Operating Cash Flow (TTM) i$-4,171,734$8.29B
Levered Free Cash Flow (TTM) i$-6,115,827$5.51B
Dividends
Last 12-Month Dividend Yield iN/A0.38%
Last 12-Month Dividend iN/A$1.76

Valuation & Enterprise Metrics Analysis: Burning Rock Biotech Ltd. vs Thermo Fisher Scientific Inc.

MetricBNR (Apr 24, 2026)TMO (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i-0.6125.84
Forward P/E i-35.6017.16
PEG Ratio i0.012.29
Price to Sales (TTM) i0.413.86
Price to Book (MRQ) i2.763.31
Market Capitalization
Market Capitalization i$221.68M$174.55B
Enterprise Value i$253.48M$214.76B
Enterprise Value Metrics
Enterprise to Revenue i3.204.75
Enterprise to EBITDA i-499.7719.02
Risk & Other Metrics
Beta i1.600.97
Book Value per Share (MRQ) i$7.49$141.96

Financial Statements Comparison: Burning Rock Biotech Ltd. vs Thermo Fisher Scientific Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBNR (2024)TMO (2025)
Revenue/Sales i515.82M44.56B
Cost of Goods Sold i153.42M26.32B
COGS % of Revenue i29.7%59.1%
Gross Profit i362.40M18.24B
Gross Margin i70.3%40.9%
Research & Development i232.29M1.40B
Operating Income (EBIT) i-322.43M8.11B
Operating Margin i-62.5%18.2%
EBITDA i-235.01M11.86B
EBITDA Margin i-45.6%26.6%
Pre-Tax Income i-340.74M7.31B
Pre-Tax Income % of Revenue i-66.1%16.4%
Income Tax i5.89M547.00M
Income Tax % of Revenue i1.1%1.2%
Net Income (Profit) i-346.63M6.72B
Profit Margin i-67.2%15.1%

Balance Sheet & Liquidity Metrics

MetricBNR (2024)TMO (2025)
Cash & Equivalents i519.85M9.85B
Total Current Assets i776.62M28.71B
Total Current Assets % of Revenue i150.6%64.4%
Total Current Liabilities i266.30M15.19B
Total Current Liabilities % of Revenue i51.6%34.1%
Long-Term Debt i27.75M35.85B
Long-Term Debt % of Revenue i5.4%80.5%
Total Shareholders Equity i580.83M53.54B
Retained Earnings i-4.20B59.16B
Retained Earnings % of Revenue i-814.3%132.8%
Property, Plant & Equipment i105.39M0

Cash Flow Statement Comparison

MetricBNR (2024)TMO (2025)
Operating Cash Flow i-159.58M7.82B
Operating Cash Flow % of Revenue i-30.9%17.5%
Capital Expenditures i-3.85M-1.48B
Free Cash Flow i-98.24M6.29B
FCF Margin i-19.0%14.1%
Debt Repayment i0-3.51B
Common Stock Repurchase i-72,000-3.00B

Short Interest & Institutional Ownership Analysis

MetricBNRTMO
Shares Short i63,9464.54M
Short Ratio i1.932.38
Short % of Float i0.87%1.22%
Shares Outstanding i9.03M371.62M
Float Shares i44.05M371.07M
% Held by Insiders i3.92%0.17%
% Held by Institutions i44.73%95.23%
% Held by Public i51.35%4.60%

Dividend Analysis & Yield Comparison: Burning Rock Biotech Ltd. vs Thermo Fisher Scientific Inc.

MetricBNRTMO
Last 12-Month Dividend iN/A$1.76
Last 12-Month Dividend Yield iN/A0.38%
3-Year Avg Annual Dividend iN/A$1.60
3-Year Avg Dividend Yield iN/A0.08%
3-Year Total Dividends iN/A$4.80
Ex-Dividend DateN/AMar 13, 2026